Trials / Completed
CompletedNCT00915577
Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe
An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector With a Pre-Filled Liquid AVONEX® Syringe in Multiple Sclerosis Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Determine patient satisfaction with the single-use autoinjector for the delivery of pre-filled Avonex syringe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Interferon beta-1a | 30mcg, IM once-a-week |
| DEVICE | Single-use autoinjector | Single-use autoinjector with Avonex 30mcg pre-filled syringe |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2006-04-01
- Completion
- 2006-04-01
- First posted
- 2009-06-08
- Last updated
- 2009-06-08
Source: ClinicalTrials.gov record NCT00915577. Inclusion in this directory is not an endorsement.